lurtotecan has been researched along with Sensitivity and Specificity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| St Claire, RL; Stafford, CG | 1 |
| Brouwer, E; de Bruijn, P; Gill, S; Hamilton, M; Kehrer, D; Loos, WJ; Nooter, K; Sparreboom, A; Stoter, G; Verweij, J | 1 |
2 other study(ies) available for lurtotecan and Sensitivity and Specificity
| Article | Year |
|---|---|
High-performance liquid chromatographic analysis of the lactone and carboxylate forms of a topoisomerase I inhibitor (the antitumor drug GI147211) in plasma.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carboxylic Acids; Chromatography, High Pressure Liquid; Dogs; Drug Stability; Hydrogen-Ion Concentration; Lactones; Sensitivity and Specificity; Topoisomerase I Inhibitors | 1995 |
Liposomal lurtotecan (NX211): determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography.
Topics: Acetonitriles; Antineoplastic Agents; Camptothecin; Chromatography, High Pressure Liquid; Humans; Perchlorates; Sensitivity and Specificity | 2000 |